Home ETF List About

ETF Holdings Breakdown of BXP

Stock NameBeximco Pharmaceuticals Limited
TickerBXP(GBX) LSE
TYPECommon Stock
CountryUK

BXP institutional holdings

The following institutional investment holdings of BXP have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-25 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 340,760USD 25,679,674
2025-09-25 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 340,760USD 25,679,674
2025-09-25 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 340,760USD 25,679,674
2025-09-25 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 219,802USD 16,564,279
2025-09-25 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 219,802USD 16,564,279 -0.1%
2025-09-25 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 219,802USD 16,564,279
2025-09-25 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 219,802USD 16,564,279 -0.1%
2025-09-25 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 73,306USD 5,524,340
2025-09-25 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 51,543USD 3,884,280
2025-09-25 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 31,048USD 2,339,777
2025-09-25 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 31,048USD 2,339,777
2025-09-25 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 41,920USD 3,159,091
2025-09-25 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 41,920USD 3,159,091
2025-09-25 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 41,920 0.1%USD 3,159,091 -0.1%
2025-09-25 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 16,569USD 1,248,640
2025-09-25 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 20,710USD 1,336,621 0.4%
2025-09-25 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 3,105USD 233,993 -0.1%
2025-09-25 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 3,105USD 233,993
2025-09-25 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 11,629USD 876,361
2025-09-25 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 11,629USD 876,361
2025-09-25 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 124,187USD 9,358,732
2025-09-25 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 124,187 0.8%USD 9,358,732 0.6%
2025-09-25 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 10,046USD 648,368 0.4%
2025-09-25 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 6,174USD 465,273
2025-09-25 IE00B57X3V84 (iShares Dow Jones Global Sustainability Screened UCITS ETF USD (Acc)) 12,631USD 951,872 -0.1%
2025-09-25 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 2,930USD 220,805
2025-09-25 IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)) 3,954USD 297,973
2025-09-25 IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist) 3,954USD 297,973
2025-09-25 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 3,523USD 198,894
2025-09-25 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 2,630USD 198,197
2025-09-25 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 19,271USD 1,452,263
2025-09-25 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 19,271USD 1,452,263
2025-09-25 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 803USD 45,334 0.6%
2025-09-25 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 6,038USD 455,024 -0.1%
2025-09-25 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 14,727USD 1,109,827
2025-09-25 IE00BZ0PKS76 (iShares STOXX USA Equity Multifactor UCITS ETF USD (Acc)) 160USD 12,058
2025-09-25 IE00BG13YZ23 (iShares Edge MSCI USA Multifactor UCITS ETF USD (Dist)) 160USD 12,058
Total =2,635,586 USD 198,203,200
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with BXP

Piper Sandler Forecasts Strong Price Appreciation for BXP (NYSE:BXP) Stock
BXP (NYSE:BXP – Get Free Report) had its price target raised by equities research analysts at Piper Sandler from $80.00 to $90.00 in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The firm presently has an “overweight” rating on the real estate investment trust’s stock. Piper Sandler’s price target points to a […] - 2025-09-11 02:55:12
BMO Capital Markets Lowers BXP (NYSE:BXP) Price Target to $84.00
BXP (NYSE:BXP – Get Free Report) had its price target decreased by equities researchers at BMO Capital Markets from $86.00 to $84.00 in a research note issued to investors on Tuesday, Marketbeat Ratings reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. BMO Capital Markets’ price target points to […] - 2025-09-11 02:55:09
BXP (NYSE:BXP) Stock Price Expected to Rise, UBS Group Analyst Says
BXP (NYSE:BXP – Get Free Report) had its price objective boosted by equities researchers at UBS Group from $68.00 to $74.00 in a research note issued on Tuesday, MarketBeat Ratings reports. The firm presently has a “neutral” rating on the real estate investment trust’s stock. UBS Group’s price target would suggest a potential upside of […] - 2025-09-11 02:55:05
BXP (NYSE:BXP) Lowered to “In-Line” Rating by Evercore ISI
BXP (NYSE:BXP – Get Free Report) was downgraded by equities researchers at Evercore ISI from an “outperform” rating to an “in-line” rating in a report issued on Tuesday, MarketBeat.com reports. They currently have a $76.00 price target on the real estate investment trust’s stock. Evercore ISI’s price objective points to a potential upside of 2.81% […] - 2025-09-11 02:54:57
BXP (NYSE:BXP) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of BXP (NYSE:BXP – Free Report) from a sell rating to a hold rating in a report issued on Friday. Several other brokerages also recently weighed in on BXP. The Goldman Sachs Group reduced their price objective on shares of BXP from $76.00 to $68.00 and set a “neutral” rating […] - 2025-09-08 02:40:47
BXP Reaches Analyst Target Price
In recent trading, shares of BXP Inc (Symbol: BXP) have crossed above the average analyst 12-month target price of $75.12, changing hands for $75.29/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or - 2025-09-05 08:36:50
Reviewing BXP (NYSE:BXP) & Kilroy Realty (NYSE:KRC)
Kilroy Realty (NYSE:KRC – Get Free Report) and BXP (NYSE:BXP – Get Free Report) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership. Volatility and Risk Kilroy Realty has a beta of […] - 2025-09-04 04:38:59
Zacks Research Weighs in on BXP’s Q3 Earnings (NYSE:BXP)
BXP, Inc. (NYSE:BXP – Free Report) – Investment analysts at Zacks Research decreased their Q3 2025 EPS estimates for BXP in a report issued on Tuesday, August 19th. Zacks Research analyst Team now anticipates that the real estate investment trust will post earnings of $1.71 per share for the quarter, down from their previous forecast […] - 2025-08-22 02:28:53
BXP (NYSE:BXP) Downgraded to Sell Rating by Wall Street Zen
BXP (NYSE:BXP – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday. BXP has been the topic of several other reports. Truist Financial lowered their price objective on BXP from $75.00 to $71.00 and set […] - 2025-08-18 03:10:51
The Goldman Sachs Group Lowers BXP (NYSE:BXP) Price Target to $68.00
BXP (NYSE:BXP – Free Report) had its price target cut by The Goldman Sachs Group from $76.00 to $68.00 in a report published on Thursday morning,Benzinga reports. They currently have a neutral rating on the real estate investment trust’s stock. Several other research analysts have also commented on BXP. Piper Sandler decreased their price objective […] - 2025-08-15 04:24:52
BXP, Inc. (NYSE:BXP) Receives Consensus Rating of “Hold” from Brokerages
BXP, Inc. (NYSE:BXP – Get Free Report) has been assigned a consensus rating of “Hold” from the fourteen ratings firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the company. The average […] - 2025-08-11 03:00:54
Piper Sandler Cuts BXP (NYSE:BXP) Price Target to $80.00
BXP (NYSE:BXP – Free Report) had its price target reduced by Piper Sandler from $85.00 to $80.00 in a research note issued to investors on Monday,Benzinga reports. They currently have an overweight rating on the real estate investment trust’s stock. BXP has been the topic of several other reports. Mizuho reduced their price objective on […] - 2025-08-05 04:42:54
BXP (NYSE:BXP) Raised to Hold at Wall Street Zen
BXP (NYSE:BXP – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday. Several other analysts have also commented on the stock. JPMorgan Chase & Co. raised shares of BXP from an “underweight” rating […] - 2025-08-04 02:13:06
BXP (NYSE:BXP) Price Target Cut to $81.00 by Analysts at Scotiabank
BXP (NYSE:BXP – Get Free Report) had its price objective dropped by stock analysts at Scotiabank from $83.00 to $81.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s price objective points to a potential upside of 15.75% from […] - 2025-07-16 02:40:48
Beximco Pharmaceuticals (LON:BXP) Share Price Crosses Below 50-Day Moving Average – Should You Sell?
Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report)’s stock price passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 36.95 ($0.51) and traded as low as GBX 33.33 ($0.46). Beximco Pharmaceuticals shares last traded at GBX 34.71 ($0.48), with a volume of 168,031 shares […] - 2025-07-02 05:02:54
BXP (NYSE:BXP) Raised to “Neutral” at JPMorgan Chase & Co.
BXP (NYSE:BXP – Get Free Report) was upgraded by equities researchers at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a research note issued on Monday, Marketbeat.com reports. The brokerage presently has a $78.00 target price on the real estate investment trust’s stock, up from their prior target price of […] - 2025-06-25 02:58:52
BXP (NYSE:BXP) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
BXP (NYSE:BXP – Get Free Report) had its price target raised by equities researchers at BMO Capital Markets from $85.00 to $86.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. BMO Capital Markets’ target price would indicate […] - 2025-06-25 02:58:51
Truist Financial Issues Pessimistic Forecast for Boston Properties (NYSE:BXP) Stock Price
Boston Properties (NYSE:BXP – Free Report) had its price objective reduced by Truist Financial from $75.00 to $71.00 in a research report sent to investors on Tuesday morning,Benzinga reports. They currently have a hold rating on the real estate investment trust’s stock. Several other analysts have also recently commented on the stock. Wells Fargo & […] - 2025-05-28 02:50:50
UBS Group Issues Pessimistic Forecast for Boston Properties (NYSE:BXP) Stock Price
Boston Properties (NYSE:BXP – Get Free Report) had its price objective decreased by investment analysts at UBS Group from $80.00 to $68.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “neutral” rating on the real estate investment trust’s stock. UBS Group’s price objective points to a potential upside of 6.18% […] - 2025-05-07 04:44:48
What You Need To Know Ahead of BXP's Earnings Release
BXP is poised to announce its first-quarter results later this month, and analysts predict a single-digit dip in the company’s bottom-line figure. - 2025-04-17 14:32:43
Is BXP Stock Outperforming the Nasdaq?
Despite BXP’s outperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects. - 2025-04-03 10:45:15
Contrasting Boston Properties (NYSE:BXP) & Welltower (NYSE:WELL)
Welltower (NYSE:WELL – Get Free Report) and Boston Properties (NYSE:BXP – Get Free Report) are both large-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Analyst Recommendations This is a breakdown of current […] - 2025-03-28 03:34:47
Jefferies Financial Group Begins Coverage on Boston Properties (NYSE:BXP)
Investment analysts at Jefferies Financial Group initiated coverage on shares of Boston Properties (NYSE:BXP – Get Free Report) in a research note issued on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $78.00 price target on the real estate investment trust’s stock. Jefferies Financial Group’s price target would indicate a potential […] - 2025-03-19 03:52:44
Analysts Set Boston Properties, Inc. (NYSE:BXP) Price Target at $82.08
Boston Properties, Inc. (NYSE:BXP – Get Free Report) has been assigned an average rating of “Hold” from the thirteen ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating on the company. […] - 2025-03-17 04:44:52
Barclays Issues Pessimistic Forecast for Boston Properties (NYSE:BXP) Stock Price
Boston Properties (NYSE:BXP – Free Report) had its price target trimmed by Barclays from $89.00 to $79.00 in a report published on Friday,Benzinga reports. The brokerage currently has an equal weight rating on the real estate investment trust’s stock. Several other research analysts have also commented on the stock. Wedbush lowered shares of Boston Properties […] - 2025-03-17 03:48:43
Van ECK Associates Corp Boosts Stock Holdings in Boston Properties, Inc. (NYSE:BXP)
Van ECK Associates Corp boosted its position in Boston Properties, Inc. (NYSE:BXP – Free Report) by 1.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 70,444 shares of the real estate investment trust’s stock after buying an additional 1,169 shares during the quarter. […] - 2025-02-19 07:12:07
Beximco Pharmaceuticals (LON:BXP) Share Price Crosses Above Fifty Day Moving Average – Here’s Why
Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 37.33 ($0.46) and traded as high as GBX 38.50 ($0.48). Beximco Pharmaceuticals shares last traded at GBX 38.40 ($0.48), with a volume of […] - 2025-02-12 06:45:00
Critical Comparison: Boston Properties (NYSE:BXP) versus UDR (NYSE:UDR)
Boston Properties (NYSE:BXP – Get Free Report) and UDR (NYSE:UDR – Get Free Report) are both large-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership. Dividends Boston Properties pays an annual dividend of […] - 2025-02-10 15:08:27
After-Hours Earnings Report for January 28, 2025 : SYK, SBUX, CB, PKG, MANH, FFIV, LOGI, RNR, BXP, HLI, QRVO, UMBF
The following companies are expected to report earnings after hours on 01/28/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Stryker Corporation (SYK)is reporting for the quarter ending December 31, 2024. The medical products company's consensus e - 2025-01-28 17:00:01

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.